Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Neurochemical Research
|
August 19, 2007
Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway
Silvia A Mandel, Yotam Sagi, Tamar Amit
Free Radical Biology & Medicine
|
July 21, 2007
A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate
Orly Weinreb, Tamar Amit, Moussa B H Youdim
The Journal of Biological Chemistry
|
June 19, 2002
Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein
Yael Avramovich, Tamar Amit, Moussa B H Youdim
Archives of Biochemistry and Biophysics
|
January 24, 2008
The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate
Orly Weinreb, Tamar Amit, Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 2, 2011
Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim
Orly Weinreb, Silvia Mandel, Orit Bar-Am, et al.
Journal of Neurochemistry
|
July 20, 2007
Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro
Orit Bar-Am, Tamar Amit, Moussa B H Youdim
Neuroscience Letters
|
January 21, 2004
Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
Orit Bar Am, Tamar Amit, Moussa B H Youdim
Expert Opinion on Drug Discovery
|
March 19, 2013
Applying transcriptomic and proteomic knowledge to Parkinson's disease drug discovery
Silvia Mandel, Tamar Amit, Limor Kalfon, et al.
Genes & Nutrition
|
September 17, 2009
Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties
Orly Weinreb, Tamar Amit, Silvia Mandel, et al.
Neuro-Degenerative Diseases
|
December 14, 2011
Novel therapeutic approach for neurodegenerative pathologies: multitarget iron-chelating drugs regulating hypoxia-inducible factor 1 signal transduction pathway
Orly Weinreb, Tamar Amit, Silvia Mandel, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Neurochemical Research
|
August 19, 2007
Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway
Silvia A Mandel, Yotam Sagi, Tamar Amit
Free Radical Biology & Medicine
|
July 21, 2007
A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate
Orly Weinreb, Tamar Amit, Moussa B H Youdim
The Journal of Biological Chemistry
|
June 19, 2002
Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein
Yael Avramovich, Tamar Amit, Moussa B H Youdim
Archives of Biochemistry and Biophysics
|
January 24, 2008
The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate
Orly Weinreb, Tamar Amit, Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 2, 2011
Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim
Orly Weinreb, Silvia Mandel, Orit Bar-Am, et al.
Journal of Neurochemistry
|
July 20, 2007
Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro
Orit Bar-Am, Tamar Amit, Moussa B H Youdim
Neuroscience Letters
|
January 21, 2004
Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
Orit Bar Am, Tamar Amit, Moussa B H Youdim
Expert Opinion on Drug Discovery
|
March 19, 2013
Applying transcriptomic and proteomic knowledge to Parkinson's disease drug discovery
Silvia Mandel, Tamar Amit, Limor Kalfon, et al.
Genes & Nutrition
|
September 17, 2009
Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties
Orly Weinreb, Tamar Amit, Silvia Mandel, et al.
Neuro-Degenerative Diseases
|
December 14, 2011
Novel therapeutic approach for neurodegenerative pathologies: multitarget iron-chelating drugs regulating hypoxia-inducible factor 1 signal transduction pathway
Orly Weinreb, Tamar Amit, Silvia Mandel, et al.
Page
of 9